{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-028678","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.778409+00:00","generated_at":"2026-06-13T23:06:39.215201+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MindMed annual meeting adjourned; potential Nasdaq delisting risk from quorum issue","bullets":["2023 annual general meeting on June 15 failed due to lack of 33 1/3% quorum; reconvened for June 21 at 10 a.m. ET.","Articles allow meeting to proceed with whatever persons present if quorum not met within 30 minutes of reconvened meeting.","Nasdaq may issue non-compliance letter if less than 33 1/3% present; company has 45 days to submit plan, possible 180-day extension.","Potential delisting would negatively impact liquidity and market price; company believes it can regain compliance but no assurance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-028678","json":"https://secwatch.observer/filing/0000950170-23-028678.json","markdown":"https://secwatch.observer/filing/0000950170-23-028678.md","text":"https://secwatch.observer/filing/0000950170-23-028678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/0000950170-23-028678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/mnmd-20230616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:06:39.215201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}